Veletri trial pharmaceutical company?

What company makes Veletri?

Veletri (epoprostenol) is marketed by Gilead Sciences.

Which company ran the clinical trials for Veletri?

Clinical development and early trials for Veletri/epoprostenol have historically been conducted through the manufacturer/partners responsible for epoprostenol’s development and later global commercialization work tied to Gilead. Public trial listings are sometimes sponsored by the company named in the registry entry rather than a single parent brand, so the exact “trial sponsor” can vary by study.

Is Veletri tied to Gilead’s pulmonary hypertension portfolio?

Yes. Veletri is used in pulmonary arterial hypertension, and Gilead has been associated with commercializing therapies in this area, including Veletri.

How to confirm the specific sponsor for a particular Veletri study

If you tell me the trial identifier (for example, an NCT number) or the study title, I can help you pinpoint the exact sponsor/company listed for that specific trial.